KT185 is an orally-bioavailable, brain-penetrant and selective ABHD6 inhibitor, with an IC 50 0.21 nM in Neuro2A cells.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > MAGL
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.